Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Study sponsor: Vanda Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-11Estimated
Enrollment · participants420Estimated
Source updated2026-06-05Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.